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Results Eleven studies including 190 patients were 
included. In eight studies, grafts were harvested from the 
femoral condyle, in three studies, from either the 5th or 6th 
costal-osteochondral junction. The average number of grafts 
was 2 (1–5); graft diameter ranged from 2.6 to 11 mm. In 
the knee-to-elbow group, donor-site morbidity was reported 
in 10 of 128 patients (7.8%), knee pain during activity (7.0%) 
and locking sensations (0.8%). In the rib-to-elbow group, 
one of 62 cases (1.6%) was complicated, a pneumothorax. 
The proportion in the knee-to-elbow group was 0.04 (95% 
CI 0.0–0.15), and the proportion in the rib-to-elbow group 
was 0.01 (95% CI 0.00–0.06). There were no significant dif-
ferences between both harvest techniques (n.s.).
Conclusions Donor-site morbidity after OATS for capi-
tellar osteochondritis dissecans was reported in a consider-
able group of patients.
Level of evidence Level IV, systematic review of level IV 
studies.
Abstract 
Purpose To determine the rate of donor-site morbidity 
after osteochondral autologous transplantation (OATS) for 
capitellar osteochondritis dissecans.
Methods A literature search was performed in PubMed/
MEDLINE, Embase, and Cochrane Library to identify 
studies up to November 6, 2016. Criteria for inclusion were 
OATS for capitellar osteochondritis dissecans, reported 
outcomes related to donor sites, ≥10 patients, ≥1 year 
follow-up, and written in English. Donor-site morbidity 
was defined as persistent symptoms (≥1 year) or cases that 
required subsequent intervention. Patient and harvest char-
acteristics were described, as well as the rate of donor-site 
morbidity. A random effects model was used to calculate 
and compare weighted group proportions.
Electronic supplementary material The online version of this 
article (doi:10.1007/s00167-017-4516-8) contains supplementary 
material, which is available to authorized users.
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Introduction
Osteochondritis dissecans (OCD) of the capitellum is a 
disorder of the subchondral bone and articular cartilage 
[3, 23, 32]. This condition is primarily seen in teenagers 
engaged in sporting activities in which the elbow is repeti-
tively exposed to extensive valgus forces, such as baseball 
and gymnastics [3, 23, 32]. In early phases, a stable capitel-
lar OCD may cause pain and effusion, while in advanced 
stages, the OCD may become unstable and cause locking, 
restricted range of motion, and instability [3, 23, 32]. Sta-
ble OCD may initially be treated nonoperatively with activ-
ity modification and physical therapy [17, 18], whereas 
unstable lesions require operative treatment. Several surgi-
cal options have been developed over the past two decades 
including arthroscopic debridement with or without mar-
row stimulation [13, 26, 29], fragment fixation [7, 10, 31], 
and osteochondral autologous transplantation (OATS) [15, 
16, 24, 33].
OATS has become a popular treatment option for large, 
unstable lesions (diameter > 10  mm) with lateral wall 
involvement, as well as also for athletes without an accept-
able outcome after less invasive techniques [8, 15, 22, 24]. 
In OATS, a single or multiple osteochondral grafts are 
harvested from either the less-weight-bearing parts of the 
femoral condyle [8, 11, 15, 24] or the costal-osteochondral 
junction [22, 30]. The cylindrical donor plug consisting 
of hyaline cartilage and subchondral bone is then trans-
planted into the defect area to restore the integrity of the 
articular surface of the capitellum. A major disadvantage of 
this procedure is the need to harvest one or multiple grafts 
from an asymptomatic knee or the rib area in an adoles-
cent athlete and thus the risk for morbidity at the donor 
site [2, 12, 27]. Recently, a review conducted by Andrade 
et al. reported knee donor-site morbidity rates of 17% and 
6% for ankle and knee mosaicplasty procedures, respec-
tively [2]. In contrast, two studies involving adolescent 
athletes who underwent OATS for OCD of the capitellum 
found no adverse effects related to the donor site [9, 35]. 
Interestingly, Weigelt et  al. reported substantial donor-site 
morbidity in eight of 14 patients treated for capitellar OCD 
[33]. The vast majority of patients with capitellar OCD 
are high-demand athletes who are younger than patients 
with knee and ankle OCD [2, 9]. Also, as opposed to knee 
and ankle OCD, grafts have been harvested from both the 
femoral condyle and costal-osteochondral junction in the 
treatment of capitellar OCD [9, 30]. Knowing the overall 
risk for donor-site morbidity following capitellar OATS is 
relevant in surgical decision making, as well as it is essen-
tial to be able to counsel patients about the risk for possible 
donor-site effects. To our knowledge, the risk of donor-site 
morbidity after OATS in this particular population is still 
unknown.
The purpose of this study was to determine the rate of 
donor-site morbidity following osteochondral autologous 
transplantation for capitellar osteochondritis dissecans. The 
hypothesis op the study was that there would be no dif-
ference in the proportion of donor-site morbidity between 




The findings of this systematic review were reported 
according to the Preferred Reporting Items for Systematic 
Review and Meta-Analyses (PRISMA) guidelines [14].
Selection criteria
Studies that met the following inclusion criteria were 
included: (1) osteochondral autologous transplantation for 
capitellar OCD, (2) reported outcomes related to the donor 
site, (3) minimum inclusion of 10 patients, (4) minimum 
follow-up of one year, and (5) written in English. Case 
reports, reviews, and cadaveric studies were excluded. 
Donor-site morbidity was defined as the presence of persis-
tent symptoms (≥1 year) after graft harvesting, as well as 
the need for subsequent intervention to treat complications 
related to the donor site.
Search strategy
A literature search was performed in the following data-
bases up to November 6, 2016: PubMed/MEDLINE, 
Embase, and the Cochrane Library. The PubMed/MED-
LINE search strategy was adjusted into similar search strat-
egies for other databases (Online Appendix  1). Reference 
lists of retrieved studies were manually searched for addi-
tional studies potentially meeting the inclusion criteria.
Study selection
Study selection was independently performed by two 
authors. First, title and abstract were screened to identify 
potentially relevant papers (R.B. and P.O.). These results 
were verified by two senior authors (L.O. and M.v.d.B.). 
Subsequently, manuscripts were retrieved when title or 
abstract revealed insufficient information to determine the 
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appropriateness for inclusion. Disagreement was resolved 
by discussion or with arbitration when necessary by the 
senior authors (L.O. and M.v.d.B.) when differences 
remained.
Data extraction
The main outcome of interest was the presence or absence 
of donor-site morbidity (persistent symptoms or need for 
subsequent intervention) after capitellar OATS. The fol-
lowing data were extracted from each study: author names, 
year of publication, patient demographics, follow-up time, 
harvest method, graft characteristics, and the use of fill-
ers. The following outcomes related to the donor site were 
extracted: symptoms (e.g., pain, locking, and instability), 
physical examination (e.g., effusion and range of motion), 
complications (e.g., infection, nerve injury, or subse-
quent treatment), patient reported outcome scores, imag-
ing evaluation [e.g., radiographs, computed tomography, 
or magnetic resonance imaging (MRI)], and anatomic and 
histological outcomes. Data extraction was independently 
performed by two authors (R.B. and P.O.) and verified by 
two senior authors (L.O. and M.v.d.B.). Articles were not 
blinded for author, affiliation, and source.
Methodological quality assessment
Two authors (R.B. and P.O.) independently judged the 
methodological quality of included studies using the check-
list for quality appraisal of case series studies that was 
developed at the Institute of Health Economics (IHE) [5, 
20]. Each of the 20 criteria of the checklist were answered 
with either ‘yes,’ ‘no,’ or ‘partial’ or ‘unclear.’ For esti-
mating the risk of bias for each study, ‘partial’ responses 
were considered ‘yes,’ and ‘unclear’ responses were con-
sidered ‘no.’ A study with 0–2 ‘no’ responses was consid-
ered to have a low risk of bias, 3–5 ‘no’ responses a moder-
ate risk, 6–8 ‘no’ responses a high risk, and 9 or more ‘no’ 
responses a very high risk of bias. In case of disagreement, 
two senior authors (L.O. and M.v.d.B.) were involved to 
solve the differences.
Statistical analysis
Categorical data were displayed as absolute numbers with 
frequencies; continuous data were displayed as means with 
sample range.
The main outcomes of interest were the rate of donor-
site morbidity within the knee-to-elbow group and rib-to-
elbow group. Proportions of donor-site morbidity were 
calculated for each study using the Freeman-Tukey dou-
ble arcsine transformation. Subsequently, a random effects 
model, to account for heterogeneity across studies, was 
used to calculate weighted group proportions for each har-
vest technique, and to compare proportions between the 
two techniques [19, 34]. A p value <0.05 was considered 
significant. Statistical analyses were performed with the 
use of Stata 13.0 (College Station, TX, USA).
Results
Population and harvest characteristics
A detailed summary of patient and harvest characteristics 
for each study is given in Table  1. A total of 11 studies 
including 190 patients met the criteria after careful sys-
tematic selection (Fig. 1) [9, 11, 15, 16, 21, 22, 24, 28, 30, 
33, 35]. The mean age across the selected studies was 15 
years (range, 14–18), and the mean follow-up length was 
37 months (range, 22–84).
The knee served as the donor site in 128 patients across 
eight studies (Table 1) [9, 11, 15, 16, 21, 24, 33, 35]. The 
average number of grafts harvested was 2 (range 1–5) 
[9, 16, 21, 33, 35], and graft diameter ranged from 2.6 
to 11  mm [9, 16, 21, 33, 35]. In 62 patients across three 
studies, either the 5th or 6th costal-osteochondral junction 
served as the harvest site [22, 28, 30]. Either one or two 
grafts were harvested for each patient [22, 28, 30].
Donor-site morbidity
A detailed summary of donor-site effects per study is given 
in Table 2. In the knee-to-elbow group, donor-site morbid-
ity after capitellar OATS was reported in 10 of 128 patients, 
resulting in a donor-site morbidity rate of 7.8%. Knee pain 
while stair climbing and heavy lifting were reported in nine 
patients (7.0%) and locking sensations in one patient (0.8%) 
(Table 2) [9, 16, 33]. In the rib-to-elbow group, donor-site 
morbidity was reported in one of 62 patients, resulting in 
a donor-site morbidity rate of 1.6%. One case was com-
plicated by a pneumothorax due to damage to the costal 
pleura, which required insertion of a chest tube [30].
The proportion of donor-site morbidity in the knee-to-
elbow group was 0.04 (95% CI 0.0–0.15), and the propor-
tion in the rib-to-elbow group was 0.01 (95% CI 0.00–0.06) 
(Fig.  2). There was no significant difference between the 
two harvest techniques in terms of proportion of donor-site 
morbidity (p > 0.05).
Methodological quality
The results of methodological quality assessment of indi-
vidual studies using the IHE scale are presented in Table 3. 
According to the criteria of the IHE checklist for critical 
appraisal of case series studies, the estimated potential 
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risk of bias was low for one study [21], moderate for nine 
studies [9, 11, 15, 16, 22, 24, 30, 33, 35], and high for one 
study [28]. Solely ‘no’ responses were awarded to question 
3 and 11, which are related to the patient recruitment pro-
cess and blinding of outcome assessors, respectively. Here, 
no study recruited patients from multiple centers, nor was 
outcome assessment blinded. Three more questions, also 
related to outcome measures (10, measures established 
a priori; 12, appropriateness of measures; 13, before and 
after intervention measured), were awarded with ‘no’ or 
‘partial’ responses in more than half of the included stud-
ies. By contrast, most criteria with regard to the study aim 
(question 1), study population (question 5–7), intervention 
(question 8), statistical analysis (question 14), results/con-
clusions (question 15–19), and sources of support (question 
20) were awarded a ‘yes’ response.
Discussion
The most important finding of the present study is that 
donor-site morbidity after osteochondral autologous trans-
plantation for capitellar osteochondritis dissecans occurred 
in 7.8% within the knee-to-elbow group and 1.6% within 
the rib-to-elbow group. In the knee-to-elbow group, knee 
pain during daily activities (7.0%) and locking sensa-
tions (0.8%) were reported; in the rib-to-elbow group, one 
case was complicated by a pneumothorax. There was no 
significant difference in proportion of donor-site morbid-
ity between the two harvest techniques. The findings of this 
systematic review emphasize the importance of associated 
donor-site morbidity following graft harvesting in the treat-
ment of capitellar OCD.
The rate of donor-site morbidity in our study is com-
parable to the morbidity rate after knee-to-knee OATS 
(6%), as reported by Andrade et  al. [2]. Interestingly, the 
authors reported a higher rate after knee-to-ankle OATS 
(17%) [32]. The higher rate compared to our findings may 
be the result of more grafts that were harvested (three ver-
sus two) [2], although the influence of the number of grafts 
on morbidity is controversial [1, 2, 25, 27]. Patient charac-
teristics may have played a role as well. The vast majority 
of patients in our study were adolescent (15 years), high-
demanding athletes, while patients with talar OCD are typi-
cally older (32 years [25]). We hypothesized that patients 
in our study may have been in a better physical condition 
before treatment, and therefore faster recovery with less 
donor-site effects may be expected.
In the present study, the rate of donor-site morbidity 
ranged from 0 to 57% in studies in whom grafts were har-
vested from the knee. Weigelt et al. reported morbidity in 
eight of 14 patients (57%): occasional pain during heavy 
lifting in seven patients and intermittent locking sensations 
in one patient [33]. The advanced age after a relative long 
follow-up (7 years) may be the reason for more morbidity, 
as well as it may be the result of large grafts (8–11 mm) 
Fig. 1  Flowchart of search 
strategy following PRISMA 
(preferred reporting items for 
systematic reviews and meta-
analyses) guidelines
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that were harvested [1, 2, 25, 27]. Two included studies 
focused on donor-site effects in particular [9, 21]. Despite 
encouraging clinical results reported by Iwasaki et al., MRI 
evaluation revealed alterations in signal intensity in 89% of 
donor sites, suggesting fibrous filling of donor holes [9]. 
Long-term follow-up is needed to see if these changes in 
signal intensity are permanent and clinically meaningful. 
Nishimura et  al. found a delay in recovery of quadriceps 
muscle strength [21]. This indicates that even if symptoms 
may resolve quickly after harvesting, the donor knee is at 
risk for injury due to muscle weakness within the first year. 
Three studies attempted to prevent postoperative bleed-
ing by filling donor tunnels [9, 15, 21]. As included stud-
ies were limited by small case series, potential beneficial 
effects remain unclear. Favorable results have been reported 
using synthetic implants in repair of knee OCD [4, 6], 
although literature lacks large sample comparison studies.
Three studies that were included in this review harvested 
grafts from either the 5th or 6th costal-osteochondral junc-
tion to repair capitellar OCD [22, 28, 30]. Although hard 
scar tissue was detected in palpation, radiographs showed 
new subperiostal bone formation and no long-term symp-
toms were observed [30]. However, harvesting grafts from 
the rib area is a technically demanding procedure that has 
been described by only a few studies. Most surgeons who 
perform capitellar OATS are more familiar with knee anat-
omy rather than rib anatomy. Moreover, risk for devastating 
donor-site morbidity remains as harvesting may be com-
plicated by a pneumothorax due to close proximity to the 
costal pleura, which may lead to a prolonged hospital stay 
[30]. If familiar with this technique, this may be an option 
in the treatment of large capitellar OCDs (>15  mm). As 
large lesions usually require multiple cylindrical grafts, one 
may want to avoid the risk for donor-site morbidity of the 
knee.
Table 2  Donor-site effects after osteochondral autologous transplantation for capitellar osteochondritis dissecans
IKDC International Knee Documentation Committee, MRI magnetic resonance imaging, pt patient
Author Complications Physical examination Patient reported outcomes Imaging
Knee-to-elbow osteochondral autologous transplantation (N = 128)
 Yamamoto No No effusion No pain –
 Iwasaki No Effusion up to 5 weeks in 8 pts 
(mean: 3 weeks); full range of 
motion; thigh and calf girth 
100%
Lysholm 99.6 (range 96–100), 
IKDC normal, 1 pt had knee 
pain with stair climbing at final 
follow-up
MRI: 50–100% defect fill in 6 pts 
(67%), normal signals in 4 pts 
at donor sites (44%), effusion in 
1 pt, no subchondral edema or 
hypertrophic changes at donor 
site
 Ovesen No – No pain –
 Nishimura No No effusion at 3 months; 80% 
muscle strength at 6 months, 
11 pts regained strength at 
1 year
Lysholm 100 at 6 months; Visual 
Analog Scale 0 at 3 months; 
100% return to sports without 
any donor knee disturbances
Radiographs: absence of osteoar-
thritis at 2 years
 Kosaka No – ‘None of the donor knees which 
were removed of osteocartilagi-
nous tissues experienced nega-
tive effects’
–
 Maruyama No Full range of motion Lysholm 99.8; 1 pt had mild ante-
rior knee pain during exercise
–
 Weigelt No – Lysholm 90.9; 7 patients occa-
sional pain during lifting, 1 
locking sensations
–
 Lyons No – ‘No complaints regarding the 
donor knee at final follow-up’
–
Rib-to-elbow osteochondral autologous transplantation (N = 62)
 Sato No – 2–3 days pain postoperatively; 




resolved after tube 
insertion
Hard scar tissue Few days pain postoperatively Radiographs: subperiostal bone 
formation in some pts
 Nishinaka No – No pain or symptoms –
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Using the IHE scale to evaluate the methodological 
quality of included studies [5, 20], the estimated poten-
tial risk of bias ranged from low to high, with the major-
ity of studies found to be of moderate risk of bias (9 of 
11). Studies scored the lowest on criteria related to out-
come measures, as well as on the fact that cases were 
collected in a single center in each study. Therefore, 
the findings of this systematic review should be inter-
preted by taking into account some limitations. First, a 
major limitation is the incomplete reporting regarding 
outcomes related to the donor site. As physical examina-
tion or imaging was rarely thoroughly reported, studies 
lack objective assessment of donor-site effects. Addition-
ally, subjective assessment of knee function by means of 
patient reported outcome measures was only performed 
in four of eight studies (Lysholm score) [9, 16, 21, 33]. 
In the remaining studies, no attempt was made to evaluate 
knee function, nor was physical examination thoroughly 
described [11, 15, 24, 35], as this was also the case in 
two rib-to-elbow studies [22, 28]. Also, in none of the 
included studies, either subjective or objective preopera-
tive assessment of the donor site was reported. As data 
were obtained from studies that evaluated donor-site 
effects in varying degrees, we hypothesized that donor-
site morbidity may be substantially underreported in this 
population. Also, due to incomplete reporting, we were 
unable to investigate associations between morbidity and 
harvest characteristics including donor-site location and 
the size or number of grafts. Second, included studies 
are limited by case series with small numbers of patients 
because capitellar OCD is a rare condition in the general 
population, and capitellar OATS is a relatively new pro-
cedure. Third, after pooling the data of included stud-
ies, we found no significant difference between the pro-
portions of donor-site morbidity for the knee-to-elbow 
group and the rib-to-elbow group (p > 0.05). One may 
argue whether it is valid to combine study data because 
of between-study variance; however, we attempted to 
alleviate statistical heterogeneity with the use of a ran-
dom effects model. This model has been used previously 
in systematic reviews who pooled data from case series 
studies [19, 34].
Future studies should comprehensively evaluate effects 
related to the donor site. Patient’s symptoms and physical 
examination should be reported for each patient. Addi-
tionally, the use of a patient reported outcome measure 
to assess knee function should be a routine part of clini-
cal evaluation, both preoperatively and postoperatively. 
Radiographs should be performed to evaluate potential 
progression to osteoarthritis at 1 year and may be per-
formed in cases in which donor fillers were used. MRI 
evaluation should, because of cost-effectiveness reasons, 
only be ordered in case of persistent symptoms. Besides 
the evaluation of donor-site effects, harvest character-
istics should be reported in great detail, such as donor 
location, number of grafts, graft diameter, and depth. 
Also, alternative harvest methods should be investigated 
to have no longer the need to violate the integrity of an 
asymptomatic knee or rib in an adolescent athlete.
The findings of the present investigation demonstrate a 
considerable risk for donor-site morbidity following capi-
tellar OATS. Although good-to-excellent results related to 
the elbow have been reported after capitellar OATS, sur-
geons should be aware of the risk for donor-site morbidity 
and patients should be counseled about this issue. Knowing 
the overall risk for donor-site morbidity is also relevant in 
surgical decision making. Taking this into consideration, 
surgeons could consider other resurfacing techniques such 
as allografting or autologous chondrocyte transplantation.
Conclusions
Osteochondral autologous transplantation in the treat-
ment of capitellar osteochondritis dissecans may lead to 
donor-site morbidity in a considerable group of patients, 
either after harvesting from the femoral condyle (7.8%) 
or costal-osteochondral junction (1.6%).
Fig. 2  Forest plot analysis demonstrating donor-site morbidity pro-
portions after capitellar osteochondral autologous transplantation. 
The proportion of donor-site morbidity in the knee-to-elbow group 
was 0.04 (95% CI 0.0–0.15), and the proportion in the rib-to-elbow 
group was 0.01 (95% CI 0.0–0.06). There was no difference between 
harvest techniques in terms of proportion of donor-site morbidity 
(n.s.)
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